Original Source(s)
Related Content
FDA Approves Low-Dose Macrocyclic Contrast Agent for MRI
The macrocyclic gadolinium-based contrast agent has a recommended dose of 0.01 mmol/kg actual body weight.
June 15, 2026
-
3 min